#demis-hassabis

Demis Hassabis, CEO of Google DeepMind, praised an AI-enhanced mouse pointer technology as 'pretty magical', drawing attention to a new frontier in human-computer interaction.

Isomorphic Labs, the AI drug discovery company founded by DeepMind's Demis Hassabis, has raised $2.1 billion in Series B funding led by Thrive Capital. The round includes Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund.